Patents by Inventor Douglas Murphy-Chutorian
Douglas Murphy-Chutorian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210322753Abstract: Disclosed herein are devices and methods related to UV disinfection of a transfer catheter during peritoneal dialysis. The transfer catheter comprises a first and second end, the second end comprising a transfer valve. The transfer valve body comprises an inlet, outlet, and a flush hole. The valve core comprises a notch configured to allow fluid flow between the various flow paths. The valve core and body are positioned off axis with respect to the fluid flow path. The transfer catheter can allow for a small volume kill zone, which can minimize the amount of UV required to disinfect the catheter.Type: ApplicationFiled: May 7, 2021Publication date: October 21, 2021Applicant: PuraCath Medical, Inc.Inventors: Douglas MURPHY-CHUTORIAN, James R. KERMODE, Justin A. LANCE, Julia A. RASOOLY, Michael RASOOLY, Charles Martin SCHWIMMER
-
Patent number: 11007361Abstract: Disclosed herein are devices and methods related to UV disinfection of a transfer catheter during peritoneal dialysis. The transfer catheter comprises a first and second end, the second end comprising a transfer valve. The transfer valve body comprises an inlet, outlet, and a flush hole. The valve core comprises a notch configured to allow fluid flow between the various flow paths. The valve core and body are positioned off axis with respect to the fluid flow path. The transfer catheter can allow for a small volume kill zone, which can minimize the amount of UV required to disinfect the catheter.Type: GrantFiled: June 4, 2015Date of Patent: May 18, 2021Assignee: PuraCath Medical, Inc.Inventors: Douglas Murphy-Chutorian, James R. Kermode, Justin A. Lance, Julia A. Rasooly, Michael Rasooly, Charles Martin Schwimmer
-
Publication number: 20150352348Abstract: Disclosed herein are devices and methods related to UV disinfection of a transfer catheter during peritoneal dialysis. The transfer catheter comprises a first and second end, the second end comprising a transfer valve. The transfer valve body comprises an inlet, outlet, and a flush hole. The valve core comprises a notch configured to allow fluid flow between the various flow paths. The valve core and body are positioned off axis with respect to the fluid flow path. The transfer catheter can allow for a small volume kill zone, which can minimize the amount of UV required to disinfect the catheter.Type: ApplicationFiled: June 4, 2015Publication date: December 10, 2015Inventors: Douglas MURPHY-CHUTORIAN, James R. KERMODE, Justin A. LANCE, Julia A. RASOOLY, Michael RASOOLY, Charles Martin SCHWIMMER
-
Publication number: 20120238996Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: ApplicationFiled: May 25, 2012Publication date: September 20, 2012Applicant: BOSTON SCIENTIFIC SCIMED, INC.Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Patent number: 8187251Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: GrantFiled: October 31, 2006Date of Patent: May 29, 2012Assignee: Boston Scientific Scimed, Inc.Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Publication number: 20070055230Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: ApplicationFiled: October 31, 2006Publication date: March 8, 2007Inventors: U. Chee, Richard Mueller, James Kermode, Curtis Tom, Douglas Murphy-Chutorian
-
Patent number: 7147633Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: GrantFiled: March 14, 2002Date of Patent: December 12, 2006Assignee: Boston Scientific Scimed, Inc.Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Publication number: 20050113759Abstract: A catheter retainer includes a spacer and an anchor that coact to maintain a catheter in a predetermined position within a mammary duct during a ductal lavage procedure. The spacer and the anchor operate together to resist angular or axial displacement of the catheter. A catheter retainer kit is disclosed as well.Type: ApplicationFiled: November 24, 2003Publication date: May 26, 2005Inventors: Richard Mueller, James Kermode, Douglas Murphy-Chutorian
-
Patent number: 6846218Abstract: A breast stabilizing and positioning device comprises a torso band for enveloping and securement about the chest of a human female patient, a breast elevating module and a breast stabilizing ring. The torso band defines a through aperture sized to receive a human breast there through. The breast elevating module is attached to the torso band, and comprises a base framing the through aperture of the torso band and a plurality of flexible, elongate tabs extending radially from the base. The breast stabilizing ring is adapted for securement about the areolar region of a human breast and defines an opening sized to receive a human breast nipple there through. The breast stabilizing ring is adapted for removable engagement with the tabs of the breast elevating module. The present devices assist in performing diagnostic procedures such as ductal lavage, or a surgical procedure, such as removal of ducts from the breast nipple.Type: GrantFiled: April 30, 2003Date of Patent: January 25, 2005Assignee: Acueity, Inc.Inventors: James Kermode, Yumee Gang, Charles M. Schwimmer, Tammy Gravelle, Douglas Murphy-Chutorian
-
Publication number: 20040219864Abstract: A breast stabilizing and positioning device comprises a torso band for enveloping and securement about the chest of a human female patient, a breast elevating module and a breast stabilizing ring. The torso band defines a through aperture sized to receive a human breast therethrough. The breast elevating module is attached to the torso band, and comprises a base framing the through aperture of the torso band and a plurality of flexible, elongate tabs extending radially from the base. The breast stabilizing ring is adapted for securement about the areolar region of a human breast and defines an opening sized to receive a human breast nipple therethrough. The breast stabilizing ring is adapted for removable engagement with the tabs of the breast elevating module. The devices of the present invention conveniently and effectively hold a human breast in a stable position suitable for performing a diagnostic procedure, such as ductal lavage, or a surgical procedure, such as removal of ducts from the breast nipple.Type: ApplicationFiled: April 30, 2003Publication date: November 4, 2004Inventors: James Kermode, Yumee Gang, Charles M. Schwimmer, Tammy Gravelle, Douglas Murphy-Chutorian
-
Publication number: 20040220588Abstract: A guide assembly for directing a medical instrument to a desired location in a patient is provided. The guide assembly comprises an arcuate guide support having a constant radius of curvature. The guide assembly further includes an introducer that has a hollow elongated sheath and a probe that is spaced from the introducer along the guide support. The longitudinal axes of the introducer and the probe intersect at a target location within the patient.Type: ApplicationFiled: May 1, 2003Publication date: November 4, 2004Inventors: James Kermode, Douglas Murphy-Chutorian
-
Publication number: 20040097833Abstract: The present invention provides a collection device and kit for collecting an exudate from a mammary duct that terminates at a human breast nipple. The collection device comprises a hollow receptacle defining an interior volume and having an open aperture sized to circumscribe the nipple and defined by a rim. The collection device further includes an absorbent pad in the interior volume, which pad is positionable to contact the nipple when the receptacle is situated over the nipple. In order to keep the collection device in place, a pressure sensitive adhesive is also provided on the collection device.Type: ApplicationFiled: November 19, 2002Publication date: May 20, 2004Inventors: Richard L. Mueller,, James Kermode, Tammy Gravelle, Todd Thompson, Douglas Murphy-Chutorian
-
Patent number: 6706011Abstract: A drug delivery apparatus for dispensing predetermined volumes of drug, drug solution or other substances into an opening, such as a TMR channel in the human heart, or other laser treated area within the human body, the apparatus consisting of a bifurcated needle with a laser inlet for guiding a laser delivery means, such as an optical fiber or fiber bundle, to adjacent a surface of the human heart or other body structure for creating an opening, such as a TMR channel, or other laser treated area thereon. A drug inlet is for receiving the drug and transmitting the drug to the TMR channel or other laser treated area. Optionally, a piercing tip and/or suction device assists in positioning the apparatus adjacent the tissue to be treated. Drug is dispensed by manually or automatically actuating a piston or syringe element. A method of use is also disclosed.Type: GrantFiled: April 8, 1999Date of Patent: March 16, 2004Inventors: Douglas Murphy-Chutorian, Richard L. Mueller, Stuart D. Harman, Steve A. Daniel, Larry Witham, Bruce Richardson
-
Patent number: 6620153Abstract: An apparatus for stimulating revascularization of myocardium tissue in the ventricular wall of a human heart is disclosed. The apparatus includes means for moving the distal end of an optical fiber element forwardly through the epicardium of the heart and into the myocardium and emitting relatively low power bursts of laser energy from the distal end to form stimulus injury zones that promote capillary growth and tissue revascularization. Each penetration of the optical fiber element may produce multiple stimulus zones spaced radially from or in line with the axis of the optical fiber element. Apparatus for moving the optical fiber element and controlling the laser emissions in a predetermined manner is also disclosed.Type: GrantFiled: May 11, 2001Date of Patent: September 16, 2003Inventors: Richard L. Mueller, Douglas Murphy-Chutorian, Stuart D. Harman
-
Publication number: 20030073985Abstract: A method and device for causing angiogenesis in the heart including the formation of a pattern of stimulus pockets or zones and channels. Laser energy is deliverable through one or more fiber optic elements at a controlled penetration depth and direction. The fiber element of the device is advanced incrementally within the myocardium. Laser bursts are triggered at intervals to create stimulus zones and/or channels.Type: ApplicationFiled: May 11, 2001Publication date: April 17, 2003Inventors: Richard L. Mueller, Douglas Murphy-Chutorian, Stuart D. Harman
-
Publication number: 20020183738Abstract: Methods and apparatus of embodiments of the invention are adapted to treat tissue inside a patient's body. Aspects of the invention can be used in a wide variety of applications, but certain embodiments provide minimally invasive alternatives for treating atrial fibrillation by delivering a tissue-damaging agent to selected areas of the heart. One exemplary embodiment of the invention provides a method of treating cardiac arrhythmia. This method includes positioning a distal tissue-contacting portion of a body in surface contact with a tissue surface of cardiac tissue; detecting the surface contact between the tissue-contacting portion and the tissue surface; and thereafter, injecting a tissue-ablating agent into the cardiac tissue through the tissue-contacting portion of the body.Type: ApplicationFiled: March 14, 2002Publication date: December 5, 2002Inventors: U. Hiram Chee, Richard L. Mueller, James R. Kermode, Curtis P. Tom, Douglas Murphy-Chutorian
-
Publication number: 20020042639Abstract: A method of selecting laser parameters for performing laser-assisted myocardial revascularization to avoid inducing undesired cardiac arrhythmia without synchronization of delivery of laser energy and the patient's cardiac cycle, the method comprising the steps of minimizing the power level of laser energy used, thereby decreasing the overall trauma to the heart, selecting a pulse frequency as great as possible while avoiding adverse summation effects, selecting a pulse width as wide as possible to prevent excessively high peak powers per pulse and not so wide as to cause undesired thermal damage, selecting an energy flux rate, shaping the front end of each pulse of laser energy to provide efficient, non-explosive TMR channeling, and correcting the selected power level, pulse width, pulse frequency and energy flux rate for mechanical events, including method of access to the heart, position of selected portions of myocardium in the heart, temporal duration of the procedure, natural movement of the heart, specType: ApplicationFiled: May 14, 2001Publication date: April 11, 2002Inventors: Douglas Murphy-Chutorian, Richard L. Mueller, Stuart D. Harman, Jeffrey J. Giba, Mark Roush, Fred G. Kinley
-
Patent number: 6024703Abstract: A treatment tool such as a catheter, MIS or other surgical tool apparatus for placement within a heart chamber, organ aperture or other body opening and axial ranging therein, the apparatus particularly adapted for laser-assisted percutaneous transmyocardial revascularization (MTR). At the distal end of the tool is an annular ultrasound transducer with associated structure, positioned to transmit ultrasound signals substantially axially aligned with the axis of the treatment tool to the cardiovascular tissue, the transducer further receiving returning signals from the cardiovascular tissue to be treated. In a preferred embodiment, the transducer comprises a piezoelectric crystal material. The transducer assembly is attached to the distal tip of the tool such that a laser delivery means or other functional device can be extended through the lumen of the tool and the annular ultrasound transducer.Type: GrantFiled: May 7, 1997Date of Patent: February 15, 2000Assignee: Eclipse Surgical Technologies, Inc.Inventors: Claudio I. Zanelli, Jeffrey J. Giba, Michael A. Davis, Douglas Murphy-Chutorian
-
Patent number: 5999678Abstract: A drug delivery apparatus for dispensing a predetermined amount of one or more drugs into a laser created opening in the human body, the apparatus consisting of a laser delivery means such as an optical fiber or fiber bundle, a drug conduit which transfers the one or more drugs, drug solutions or other substances to the distal end of the laser delivery means, and the laser delivery means disposed essentially coaxially with the drug conduit. Laser delivery means is used to create a TMR channel or other opening in the body. Dispensed drug or other substance travels through the drug conduit and emanates from the drug conduit to be delivered into the TMR channel or other laser created opening. Drug is dispensed by manually or automatically activating an electric motor which actuates a piston element. A method of use is also disclosed.Type: GrantFiled: December 27, 1996Date of Patent: December 7, 1999Assignee: Eclipse Surgical Technologies, Inc.Inventors: Douglas Murphy-Chutorian, Richard L. Mueller, Stuart D. Harman, Steve A. Daniel, Larry Witham, Bruce Richardson
-
Patent number: 5931834Abstract: A method of selecting laser parameters for performing laser-assisted myocardial revascularization to avoid inducing undesired cardiac arrhythmia without synchronization of delivery of laser energy and the patient's cardiac cycle, the method comprising the steps of minimizing the power level of laser energy used, thereby decreasing the overall trauma to the heart, selecting a pulse frequency as great as possible while avoiding adverse summation effects, selecting a pulse width as wide as possible to prevent excessively high peak powers per pulse and not so wide as to cause undesired thermal damage, selecting an energy flux rate, shaping the front end of each pulse of laser energy to provide efficient, non-explosive TMR channeling, and correcting the selected power level, pulse width, pulse frequency and energy flux rate for mechanical events, including method of access to the heart, position of selected portions of myocardium in the heart, temporal duration of the procedure, natural movement of the heart, specType: GrantFiled: July 31, 1997Date of Patent: August 3, 1999Assignee: Eclipse Surgical Technologies, Inc.Inventors: Douglas Murphy-Chutorian, Richard L. Mueller, Stuart D. Harman, Jeffrey J. Giba, Mark Roush, Fred G. Kinley